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Figure S1. Investigation the desolvation effect of organic solvents on NR@SAs fabrication. SA solution (3 μM) was added into an Au NRs suspension (2×, 0.6 nM), followed by 12 h incubation with 20-80% ethanol or 80% EM (40% ethanol + 40% methanol) solution, respectively. After the organic solvent was removed by centrifugation and the sample was re-dispersed in DI water, the (A) UV-Vis spectra of the resultant nanoconjugates were obtained. (B) The loading capacity of SA onto Au NRs was evaluated under different desolvation conditions. TRITC-labeled SA was used for quantitative fluorescence analysis (excitation/emission: 540/572 nm).
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Figure S2. The profile of payload release from pristine nanoparticles. (A) 2.4 nM NR@DOX32:SA or NR@SA-TRITC were immersed in PBS (150 μL) and the supernatants were collected at each time point by centrifugation (3500 rpm, 10 min). DOX and SA-TRITC fluorescence was measured using a plate reader. (B) The release kinetics of drug molecules from pristine nanoparticles was further by means of a dynamic dialysis technique. 500 μL of NR@DOX32:SAs, NR@DOX128:SAs and free DOX (47.6 μM) was added into a 3.5K MWCO dialysis devices (Slide-A-Lyzer MINI Dialysis Devices, Thermal Fisher) and placed in a microcentrifuge tube that is filled with PBS (1 mL). A stir bar was used for continuous stirring (500 rpm). The fluorescence signal of drug molecules released into dialysis buffer was measured at each time point during dialysis. 
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